375 related articles for article (PubMed ID: 31644944)
1. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib.
Booth LA; Roberts JL; Dent P
Semin Cancer Biol; 2020 Nov; 66():129-139. PubMed ID: 31644944
[TBL] [Abstract][Full Text] [Related]
2. Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer.
Booth L; Poklepovic A; Dent P
Biochem Pharmacol; 2020 Aug; 178():114067. PubMed ID: 32504550
[TBL] [Abstract][Full Text] [Related]
3. Autophagy as a therapeutic mechanism to kill drug-resistant cancer cells.
Booth L; Roberts JL; Poklepovic A; Dent P
Anticancer Drugs; 2024 Feb; 35(2):177-182. PubMed ID: 37843030
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies.
Dent P; Booth L; Poklepovic A
Immunometabolism; 2020; 2(1):. PubMed ID: 31885880
[TBL] [Abstract][Full Text] [Related]
5. Not the comfy chair! Cancer drugs that act against multiple active sites.
Booth L; Poklepovic A; Dent P
Expert Opin Ther Targets; 2019 Nov; 23(11):893-901. PubMed ID: 31709855
[No Abstract] [Full Text] [Related]
6. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.
Bareford MD; Hamed HA; Tang Y; Cruickshanks N; Burow ME; Fisher PB; Moran RG; Nephew KP; Grant S; Dent P
Autophagy; 2011 Oct; 7(10):1261-2. PubMed ID: 21814046
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.
Bareford MD; Park MA; Yacoub A; Hamed HA; Tang Y; Cruickshanks N; Eulitt P; Hubbard N; Tye G; Burow ME; Fisher PB; Moran RG; Nephew KP; Grant S; Dent P
Cancer Res; 2011 Jul; 71(14):4955-67. PubMed ID: 21622715
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
[TBL] [Abstract][Full Text] [Related]
10. Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gα
Booth L; Roberts JL; Sander C; Lalani AS; Kirkwood JM; Hancock JF; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(5):700-710. PubMed ID: 30571927
[TBL] [Abstract][Full Text] [Related]
11. The role of cell signalling in the crosstalk between autophagy and apoptosis.
Booth LA; Tavallai S; Hamed HA; Cruickshanks N; Dent P
Cell Signal; 2014 Mar; 26(3):549-55. PubMed ID: 24308968
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways.
Hao H; Zhang D; Shi J; Wang Y; Chen L; Guo Y; Ma J; Jiang X; Jiang H
Anticancer Drugs; 2016 Mar; 27(3):192-203. PubMed ID: 26629768
[TBL] [Abstract][Full Text] [Related]
13. To die or not to die: that is the autophagic question.
Galluzzi L; Vicencio JM; Kepp O; Tasdemir E; Maiuri MC; Kroemer G
Curr Mol Med; 2008 Mar; 8(2):78-91. PubMed ID: 18336289
[TBL] [Abstract][Full Text] [Related]
14. Synergic Induction of Autophagic Cell Death in Anaplastic Thyroid Carcinoma.
Wächter S; Knauff F; Roth S; Keber C; Holzer K; Manoharan J; Maurer E; Bartsch DK; Di Fazio P
Cancer Invest; 2023 Apr; 41(4):405-421. PubMed ID: 36811581
[TBL] [Abstract][Full Text] [Related]
15. The complex interplay between autophagy and cell death pathways.
Ploumi C; Papandreou ME; Tavernarakis N
Biochem J; 2022 Jan; 479(1):75-90. PubMed ID: 35029627
[TBL] [Abstract][Full Text] [Related]
16. Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion.
Serrano-Oviedo L; Ortega-Muelas M; García-Cano J; Valero ML; Cimas FJ; Pascual-Serra R; Fernandez-Aroca DM; Roche O; Ruiz-Hidalgo MJ; Belandia B; Giménez-Bachs JM; Salinas AS; Sanchez-Prieto R
PLoS One; 2018; 13(7):e0200878. PubMed ID: 30048489
[TBL] [Abstract][Full Text] [Related]
17. Neratinib kills B-RAF V600E melanoma via ROS-dependent autophagosome formation and death receptor signaling.
Dent P; Booth L; Poklepovic A; Kirkwood JM
Pigment Cell Melanoma Res; 2022 Jan; 35(1):66-77. PubMed ID: 34482636
[TBL] [Abstract][Full Text] [Related]
18. BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.
Martin AP; Park MA; Mitchell C; Walker T; Rahmani M; Thorburn A; Häussinger D; Reinehr R; Grant S; Dent P
Mol Pharmacol; 2009 Aug; 76(2):327-41. PubMed ID: 19483105
[TBL] [Abstract][Full Text] [Related]
19. Resistance to apoptosis and autophagy leads to enhanced survival in Sertoli cells.
Aslani F; Sebastian T; Keidel M; Fröhlich S; Elsässer HP; Schuppe HC; Klug J; Mahavadi P; Fijak M; Bergmann M; Meinhardt A; Bhushan S
Mol Hum Reprod; 2017 Jun; 23(6):370-380. PubMed ID: 28379541
[TBL] [Abstract][Full Text] [Related]
20. Arsenic induces autophagy-dependent apoptosis via Akt inactivation and AMPK activation signaling pathways leading to neuronal cell death.
Fu SC; Lin JW; Liu JM; Liu SH; Fang KM; Su CC; Hsu RJ; Wu CC; Huang CF; Lee KI; Chen YW
Neurotoxicology; 2021 Jul; 85():133-144. PubMed ID: 34038756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
